Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jinshou Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1403-305X; OpenAlex author ID A5067621327. Sources: OpenAlex.

Their work

Papers
13 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2019: 1 paper · 2020: 6 papers · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 13

  1. Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.gendis.2023.101143↗
  2. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. Co-author DOI 10.1186/s13046-023-02698-x↗
  3. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Co-author DOI 10.1002/cac2.12204↗
  4. Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer. Co-author DOI 10.1186/s12935-021-01928-6↗
  5. High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. First author DOI 10.1186/s13045-021-01131-0↗
  6. Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.596573↗
  7. The enhancement of glycolysis regulates pancreatic cancer metastasis. Co-author DOI 10.1007/s00018-019-03278-z↗
  8. Arginine metabolism: a potential target in pancreatic cancer therapy. Co-author DOI 10.1097/cm9.0000000000001216↗
  9. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2. Co-author DOI 10.1158/1541-7786.mcr-19-0718↗
  10. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Co-author DOI 10.1186/s12943-020-01169-7↗
  11. Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer. First author DOI 10.3389/fonc.2020.01539↗
  12. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies. First author DOI 10.3389/fonc.2020.572722↗
  13. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Co-author DOI 10.1186/s12943-019-1103-2↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei You · 13 shared papers, 2019–2024 · strength 1.74
  2. Yupei Zhao · 11 shared papers, 2019–2024 · strength 1.43
  3. Gang Yang · 9 shared papers, 2019–2024 · strength 1.17
  4. Bo Ren · 7 shared papers, 2020–2024 · strength 1.01
  5. Taiping Zhang · 5 shared papers, 2019–2021 · strength 0.55
  6. Ruiyuan Xu · 4 shared papers, 2020–2021 · strength 0.53
  7. Jiangdong Qiu · 4 shared papers, 2019–2021 · strength 0.49
  8. Fangyu Zhao · 4 shared papers, 2019–2021 · strength 0.42
  9. Jie Ren · 2 shared papers, 2023–2024 · strength 0.39
  10. Yuan Chen · 3 shared papers, 2020–2021 · strength 0.38
  11. Guangyu Chen · 3 shared papers, 2020–2021 · strength 0.35
  12. Chengcheng Wang · 2 shared papers, 2021 · strength 0.29
  13. Xing Wang · 1 shared paper, 2024 · strength 0.21
  14. Mengyu Feng · 2 shared papers, 2019–2020 · strength 0.19
  15. Yueze Liu · 2 shared papers, 2019–2020 · strength 0.19
  16. Zhe Cao · 2 shared papers, 2019–2020 · strength 0.19
  17. Xing Wang · 1 shared paper, 2023 · strength 0.18
  18. Yuan Fang · 1 shared paper, 2023 · strength 0.18
  19. Bo Xu Ren · 1 shared paper, 2021 · strength 0.16
  20. Jianlu Song · 1 shared paper, 2021 · strength 0.13
  21. Rexiati Ruze · 1 shared paper, 2021 · strength 0.13
  22. Shunda Wang · 1 shared paper, 2020 · strength 0.13
  23. Cheng Ding · 1 shared paper, 2020 · strength 0.13
  24. Menghua Dai · 1 shared paper, 2020 · strength 0.13
  25. Wenhao Luo · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.